Openwater to commercialise tech platform that integrates electromagnetics for cellular level diagnosis

image credit- shutterstock

San Francisco's 'Openwater' announced the acceleration of its plans to commercialize its hospital-grade technology platform that integrates semiconductor physics, light, and sound to diagnose and treat diseases at the cellular level. The company has secured $100 million in total funding from new and existing investors to advance its mission of making advanced medical care accessible worldwide. New and existing investors include Plum Alley Ventures, Khosla Ventures, BOLD Capital Partners, Esther Dyson, and Peter Gabriel, among others.

Openwater's healthcare platform combines high-resolution infrared imaging, precision-tuned ultrasound, and targeted electromagnetic fields. This integration enables unprecedented visualization, monitoring, and treatment of biological issues. The technology can selectively destroy cancer cells while leaving healthy cells unaffected.

Preclinical and clinical studies have shown promising results, including shrinking glioblastoma tumors in mice and treating severe depression in humans. Collaborations with institutions including UCLA, the University of Arizona, the University of Pennsylvania, and Brown University have validated the technology's potential across multiple medical fields.

Openwater's open-source approach aims to accelerate medical innovation by reducing complex medical device regulatory time and costs. This strategy could cut time to market from 13 years to under 3 years, and from $658 million1,2 to around $10 million. By leveraging consumer electronics manufacturing processes, Openwater is addressing the challenge of making advanced medical capabilities more accessible and affordable globally.

Deborah Jackson, Founder, Plum Alley Ventures said, "Openwater represents a rare confluence of transformative technology, market readiness, and global impact potential. By leveraging existing consumer electronics supply chains and an open-source model, Openwater is positioned to scale quickly and cost-effectively. This could dramatically compress the typical timeline for medical innovation, potentially saving millions of lives and billions of dollars in healthcare costs. In a market hungry for affordable, accessible healthcare solutions, Openwater's platform addresses critical needs."